The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Genomic organization of the human catechol O‐methyltransferase gene and its expression from two distinct promoters
Open accessAbstract
Human genomic DNA fragments containing catechol O-methyltransferase (COMT) sequences were isolated and the exon-intron structure analysed by sequencing, PCR and comparing to the human COMT cDNA sequences. The gene contains six exons, of which exons 1 and 2 are noncoding. MB-ATG and S-ATG codons, responsible for the initiation of translation of the membrane-bound (MB) and soluble (S) forms of the enzyme, are located in exon 3. Two distinct COMT-specific transcripts, 1.3 kb and 1.5 kb, were detected in various human tissues and cell lines. Different quantities of the shorter COMT-specific mRNA in the tissues studied suggest a tissue-specific regulation of the COMT gene at transcriptional level. Mapping of the 5' ends of the COMT mRNAs showed that transcription initiates at multiple sites in two separate DNA regions, which are preceded by functional promoter sequences. The proximal promoter (P1), located between the two translation initiation codons and extending approximately 200 bp upstream of the MB-ATG initiation codon, apparently gives rise to the 1.3-kb S-COMT mRNA (S-mRNA). The distal promoter (P2) is located in a DNA fragment in front of and partly overlapping the transcription-start region of the 1.5-kb transcript, suggesting that it controls the expression of this MB-mRNA. Similarities between the rat and human COMT gene promoters are analyzed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The predominant form in peripheral tissue is the soluble isoform (S-COMT) [52].”
From Dynamic DNA methylation changes in the COMT gene promoter region in response to mental stress and its modulation by transcranial direct current stimulation (2021) · cites this paper as [52]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.229 · Cited by 3,485
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.887 · Cited by 1,631
Carlson, M., & Botstein, D. (1982) · Cell · doi:10.1016/0092-8674(82)90384-1 · Cited by 1,541
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,450
Imagawa, M. (1987) · Cell · doi:10.1016/0092-8674(87)90152-8 · Cited by 1,384
Enzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 902
Research works printed but not linked: 1
- Guldberg H. C., 1975, Catechol‐O‐methyltransferase: Pharmacological aspects and physiological role, Pharmacol. Rev., 27, 135
Cited by
Sorted by citations
Items 101–200 of 330
Lorenz, M., Paul, F., Moobed, M., Baumann, G., Zimmermann, B. F., Stangl, K., & Stangl, V. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.014 · Cited by 51
Souery, D., Lipp, O., Rivelli, S. K., Massat, I., Serretti, A., Cavallini, M. C., Ackenheil, M., Adolfsson, R., Aschauer, H. N., Blackwood, D., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991015)88:5 · Cited by 19
Certa, U., Seiler, M., Padovan, E., & Spagnoli, G. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1865 · Cited by 50
Geller, B., & Cook, E. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00251-6 · Cited by 50
Zhang, Z., Lindpaintner, K., Che, R., He, Z., Wang, P., Yang, P., Feng, G., He, L., & Shi, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0260-7 · Cited by 49
Tunbridge, E. M., Harrison, P. J., Warden, D. R., Johnston, C., Refsum, H., & Smith, A. D. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30700 · Cited by 49
Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity
Wang, M., Ma, Y., Yuan, W., Su, K., & Li, M. D. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9651-3 · Cited by 53
Hong, C. C., Thompson, H. J., Jiang, C., Hammond, G. L., Tritchler, D., Yaffe, M. J., & Boyd, N. F. (2003) · PubMed · Cited by 49
G/A1947 polymorphism in catechol‐O‐methyltransferase (COMT) gene in Parkinson's disease
Xie, T., Ho, S. L., Li, L. S. W., & Ma, O. C. K. (1997) · Movement Disorders · doi:10.1002/mds.870120325 · Cited by 48
Ozkan‐Ariksoysal, D., Kaymaz, B. T., Kosova, B., & Özsöz, M. (2008) · Analytical Chemistry · doi:10.1021/ac071407q · Cited by 47
Pharmacogenetics of lithium prophylaxis in mood disorders: Analysis of COMT, MAO‐A, and Gβ3 variants
Serretti, A., Lorenzi, C., Lilli, R., Mandelli, L., Pirovano, A., & Smeraldi, E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10357 · Cited by 47
Gosso, M. F., de Geus, E. J. C., Polderman, T. J. C., Boomsma, D. I., Heutink, P., & Posthuma, D. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.57 · Cited by 46
Chen, C.-H., Lee, Y.-R., Chung, M., Wei, F., Koong, F., Shaw, C.-K., Yeh, J., & Hsiao, K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1273 · Cited by 46
Hevir, N., Ribič-Pucelj, M., & Rižner, T. L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.019 · Cited by 45
Lafuente, A., Bernardo, M., Mas, S., Crescenti, A., Aparici, M., Gassó, P., Deulofeu, R., Mané, A., Catalán, R., & Carné, X. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.08.002 · Cited by 45
Expression of multiple catechol‐o‐methyltransferase (COMT) mRNA variants in human brain
Tunbridge, E. M., Lane, T. A., & Harrison, P. J. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30539 · Cited by 45
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
Diaz-Asper, C. M., Weinberger, D. R., & Goldberg, T. E. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.010 · Cited by 45
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies
Bisaglia, M., Greggio, E., Beltramini, M., & Bubacco, L. (2013) · The FASEB Journal · doi:10.1096/fj.12-226852 · Cited by 46
Siegrist, J., Netzer, J., Mordhorst, S., Karst, L., Gerhardt, S., Einsle, O., Richter, M., & Andexer, J. N. (2016) · FEBS Letters · doi:10.1002/1873-3468.12530 · Cited by 44
Genetics of Antipsychotic-Induced Weight Gain: Update and Current Perspectives
Kao, A. C.-C., & Müller, D. J. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.207 · Cited by 43
Retz, W., Rösler, M., Kissling, C., Wiemann, S., Hünnerkopf, R., Coogan, A. N., Thome, J., & Freitag, C. M. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0822-5 · Cited by 44
Pharmacogenomics of anticoagulants: steps toward personal dosage
Daly, A. K. (2009) · Genome Medicine · doi:10.1186/gm10 · Cited by 44
Wirgenes, K. V., Djurovic, S., Sundet, K. S., Agartz, I., Mattingsdal, M., Athanasiu, L., Melle, I. S., & Andreassen, O. A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.007 · Cited by 42
Cao, Y., Chen, Z., Jiang, H., & Chen, J. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp410296s · Cited by 41
Catechol‐O‐methyltransferase gene methylation and substance use in adolescents: the TRAILS study
van der Knaap, L. J., Schaefer, J. M., Franken, I. H. A., Verhulst, F. C., van Oort, F. V. A., & Riese, H. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12147 · Cited by 38
Kereszturi, É., Király, O., Barta, C., Molnár, N., Sasvári‐Székely, M., & Csapó, Z. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-18 · Cited by 40
Principles of Catecholamine Biosynthesis, Metabolism and Release
Schulz, C., Eisenhofer, G., & Lehnert, H. (2003) · KARGER eBooks · doi:10.1159/000074656 · Cited by 40
Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function
Wang, Y., Berndt, T. J., Gross, J. M., Peterson, M. A., So, M. J., & Knox, F. G. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.1.r248 · Cited by 40
Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex
CHEN, M., & Chen, C. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.03.005 · Cited by 38
Breast Cancer Risk Reduction and Membrane-Bound Catechol O -Methyltransferase Genetic Polymorphisms
Ji, Y., Olson, J. E., Zhang, J., Hildebrandt, M., Wang, L., Ingle, J. N., Fredericksen, Z., Sellers, T. A., Miller, W., Dixon, J. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0043 · Cited by 39
Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase
Tchivileva, I., Nackley, A. G., Qian, L., Wentworth, S. L., Conrad, M., & Diatchenko, L. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-13 · Cited by 39
Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase
Cotton, N., Stoddard, B. L., & Parson, W. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401086200 · Cited by 38
Vetterlein, A., Monzel, M., & Reuter, M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105112 · Cited by 40
Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response
Ji, Y., Biernacka, J. M., Snyder, K., Drews, M., Pelleymounter, L. L., Colby, C., Wang, L., Mrazek, D. A., & Weinshilboum, R. M. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.69 · Cited by 40
Pereira‐Caro, G., Mateos, R., Saha, S., Madrona, A., Espartero, J. L., Bravo, L., & Kroon, P. A. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101963b · Cited by 37
Shen, Z., Wu, Y., Chen, X., Chang, X., Zhou, Q., Zhou, J., Ying, H., Zheng, J. J., Duan, T., & Wang, K. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000369662 · Cited by 37
Omair, A., Lie, B. A., Reikerås, O., Holden, M., & Brox, J. I. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-76 · Cited by 39
Bodton, A. A., & Eisenhofer, G. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60746-2 · Cited by 37
Oosterhuis, B. E., LaForge, K. S., Proudnikov, D., Ho, A., Nielsen, D. A., Gianotti, R. J., Barral, S., Gordon, D., Leal, S. M., Ott, J., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30716 · Cited by 35
Omidvar, M., Stolk, L., Uitterlinden, A. G., Albert Hofman, D., van Duijn, C. M., & Tiemeier, H. W. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328317f3f8 · Cited by 35
Genetic abnormalities of chromosome 22 and the development of psychosis
Williams, N. M., & Owen, M. J. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0062-4 · Cited by 36
The V108M mutation decreases the structural stability of catechol O-methyltransferase
Rutherford, K., Alphandéry, E., McMillan, A. W., Daggett, V., & Parson, W. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.04.006 · Cited by 35
Tanaka, Y., Sasaki, M., Shiina, H., Tokizane, T., Deguchi, M., Hirata, H., Hinoda, Y., Okayama, N., Suehiro, Y., Urakami, S., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0550 · Cited by 35
Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats.
Schendzielorz, N., Rysä, A., Reenilä, I., Raasmaja, A., & Männistö, P. T. (2011) · PubMed · Cited by 35
Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland
Tenhunen, J., Heikkilä, P., Alanko, A., Heinonen, E., Akkila, J., & Ulmanen, I. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00197-4 · Cited by 35
Espinoza, S., Managò, F., Leo, D., Sotnikova, T. D., & Gainetdinov, R. R. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672436 · Cited by 34
Qian, Q., Liu, J., Wang, Y.-F., Yang, L., Guan, L., & Faraone, S. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-8 · Cited by 86
Robinson, R., Smith, S. M., Wolkenberg, S. E., Kandebo, M., Yao, L., Gibson, C. R., Harrison, S. T., Polsky-Fisher, S. L., Barrow, J. C., Manley, P. J., et al. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200109w · Cited by 34
Salatino‐Oliveira, A., Genro, J. P., Zeni, C., Polanczyk, G. V., Chazan, R., Guimarães, A. P., Callegari-Jacques, S. M., Rohde, L. A., & Hutz, M. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.025 · Cited by 33
Xu, Q. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00016 · Cited by 32
Salih, S. M., Jamaluddin, M., Salama, S. A., Fadl, A. A., Nagamani, M., & Al-Hendy, A. A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.04.020 · Cited by 32
Transcriptional Regulation of the Mouse Presenilin-1 Gene
Mitsuda, N., Roses, A. D., & Vitek, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23489 · Cited by 34
Reenilä, I., & Männistö, P. T. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1430 · Cited by 31
Low Catechol-O-methyltransferase Activity in the Brain and Blood Pressure Regulation
Masuda, M., Tsunoda, M., & Imai, K. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.202 · Cited by 30
Molecular Mechanisms in 22q11 Deletion Syndrome
Williams, N. M. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr095 · Cited by 30
Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice
Tammimäki, A., Käenmäki, M., Kambur, O., Kulesskaya, N., Keisala, T., Karvonen, E., Garcia-Horsman, A., Rauvala, H., & Männistö, P. T. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1944-2 · Cited by 30
Woods, J. S., Heyer, N. J., Russo, J. E., Martin, M. D., Pillai, P. B. S., Bammler, T. K., & Farin, F. M. (2014) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2014.867210 · Cited by 30
Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
Jatana, N., Apoorva, N., Malik, S., Sharma, A. K., & Latha, N. (2014) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524913666140109113341 · Cited by 29
Huang, H.-J., Chiang, P.-H., & Chen, S. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.04.020 · Cited by 29
Zhang, D., Rajaratnam, V. S., Al-Hendy, O., Halder, S. K., & Al-Hendy, A. A. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000363410 · Cited by 29
Du, L., Merali, Z., Poulter, M. O., Palkovits, M., Faludi, G., & Anisman, H. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.016 · Cited by 29
Parkin, G. M., Udawela, M., Gibbons, A. S., Scarr, E., & Dean, B. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0511-2 · Cited by 29
Käenmäki, M., Tammimäki, A., Garcia-Horsman, A., Myöhänen, T. T., Schendzielorz, N., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00494.x · Cited by 29
Masuda, K., Hashizume, C., Kikusui, T., Takeuchi, Y., & Mori, Y. (2004) · Journal of Veterinary Medical Science · doi:10.1292/jvms.66.183 · Cited by 29
Liang, S., Xia, Y., Hou, J., Ge, G., Zhang, J.-W., He, Y., Wang, J., Qi, X., & Yang, L. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.010 · Cited by 29
Purification methods of mammalian catechol-O-methyltransferases
Tilgmann, C., & Ulmanen, I. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(96)00117-x · Cited by 29
Zhang, L., Jin, Y., Chen, M., Huang, M. T., Harvey, R. G., Blair, I. A., & Penning, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240739 · Cited by 28
Weisz, J., Fritz-Wolz, G., Gestl, S. A., Clawson, G. A., Creveling, C. R., Liehr, J. G., & Dabbs, D. J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65057-2 · Cited by 28
Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: the role of gender
Klein, M., Schmoeger, M., Kasper, S. F., & Schosser, A. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1083615 · Cited by 27
Oeltmann, T., Carson, R. P., Shannon, J. R., Ketch, T., & Robertson, D. (2004) · Autonomic Neuroscience · doi:10.1016/j.autneu.2004.08.013 · Cited by 27
Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson’s disease
Kuzumaki, N., Suda, Y., Iwasawa, C., Narita, M., Sone, T., Watanabe, M., Maekawa, A., Matsumoto, T., Akamatsu, W., Igarashi, K., et al. (2019) · Brain · doi:10.1093/brain/awz084 · Cited by 26
Pedro, A. Q., Oppolzer, D., Bonifácio, M. J., Maia, C. J., Queiroz, J. A., & Passarinha, L. A. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1551-0 · Cited by 26
Sulik, M. J., Eisenberg, N., Spinrad, T. L., Lemery‐Chalfant, K., Swann, G., Silva, K. M., Reiser, M., Stover, D. A., & Verrelli, B. C. (2014) · Development and Psychopathology · doi:10.1017/s0954579414000807 · Cited by 28
Salama, S. A., Jamaluddin, M., Kumar, R., Hassan, M. H., & Al-Hendy, A. A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.049 · Cited by 26
Dopaminergic Genes and Substance Abuse
Uhl, G. R., Vandenbergh, D. J., Rodriguez, L. A., Miner, L. L., & Takahashi, N. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60922-9 · Cited by 26
Alazizi, A., Liu, M., Williams, F. E., Kurogi, K., Sakakibara, Y., Suiko, M., & Liu, M. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.12.016 · Cited by 25
Schendzielorz, N., Oinas, J.-P., Myöhänen, T. T., Reenilä, I., Raasmaja, A., & Männistö, P. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061392 · Cited by 25
Association of COMT and TPH-2 genes with DSM-5 based PTSD symptoms
Goenjian, A. K., Noble, E. P., Steinberg, A. M., Walling, D. P., Stepanyan, S. T., Dandekar, S., & Bailey, J. N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.034 · Cited by 25
Gupta, M., Kaur, H., Jajodia, A., Jain, S., Satyamoorthy, K., Mukerji, M., Thirthalli, J., & Kukreti, R. (2011) · Current Molecular Medicine · doi:10.2174/156652411798062386 · Cited by 25
Polymorphisms of Catechol-O-Methyltransferase in Men with Renal Cell Cancer
Tanaka, Y., Hirata, H., Chen, Z., Kikuno, N., Kawamoto, K., Majid, S., Tokizane, T., Urakami, S., Shiina, H., Nakajima, K., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0605 · Cited by 24
Rutherford, K., Bennion, B. J., Parson, W. W., & Daggett, V. (2006) · Biochemistry · doi:10.1021/bi051988i · Cited by 23
Tesch, R. D. S., Bonato, L. L., Quinelato, V., Casado, P. L., Vieira, A. R., Granjeiro, J. M., & Goes, C. P. D. Q. F. (2019) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2019.06.027 · Cited by 23
Haplotype analysis of the COMT‐ARVCF gene region in Israeli anorexia nervosa family trios
Michaelovsky, E., Frisch, A., Leor, S., Stein, D. J., Danziger, Y., Carel, C. A., Fennig, S., Mimouni, M., Klauck, S. M., Benner, A., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30230 · Cited by 23
Rutherford, K., & Daggett, V. (2009) · Biochemistry · doi:10.1021/bi900174v · Cited by 23
Nieratschker, V., Frank, J., Mühleisen, T. W., Strohmaier, J., Wendland, J. R., Schumacher, J. H., Treutlein, J., Breuer, R., Jamra, R. A., Mattheisen, M., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.06.018 · Cited by 22
Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia
Liao, S., Lin, S., Liu, C., Hsieh, M. H., Hwang, T., Liu, S., Guo, S., Hwu, H., & Chen, W. J. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00467.x · Cited by 22
Rai, V., Yadav, U., & Kumar, P. (2017) · Asian Pacific Journal of Cancer Prevention · doi:10.22034/apjcp.2017.18.5.1243 · Cited by 24
Genes of the dopaminergic system selectively modulate top-down but not bottom-up attention
Schneider, K. K., Schote, A. B., Meyer, J., & Frings, C. (2014) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-014-0320-9 · Cited by 21
Su, Y.-P., Depasquale, M. J., Liao, G., Buchler, I. P., Zhang, G., Byers, S., Carr, G. V., Barrow, J. C., & Wei, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173909 · Cited by 21
Hintsanen, M., Elovainio, M. J., Puttonen, S., Mika Kivimaki, B., Lehtimäki, T. J., Kähönen, M. A. P., Juonala, M., Rontu, R., Viikari, J. S. A., Raitakari, O. T., et al. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318165c7ec · Cited by 21
Dean, B., Parkin, G. M., & Gibbons, A. S. (2020) · Experimental Brain Research · doi:10.1007/s00221-020-05730-0 · Cited by 20
Genetic Variants and Early Cigarette Smoking and Nicotine Dependence Phenotypes in Adolescents
O'Loughlin, J., Sylvestre, M.-P., Labbe, A., Low, N. C., Roy-Gagnon, M.-H., Dugas, E. N., Karp, I., & Engert, J. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115716 · Cited by 21
Byers, S., Buchler, I. P., Depasquale, M. J., Rowley, H. L., Kulkarni, R. S., Pinder, L., Kolobova, A., Li, C., Au, V., Akuma, D., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05566-0 · Cited by 21
Wiegand, A., Blickle, A., Brückmann, C., Weller, S., Nieratschker, V., & Plewnia, C. (2021) · Biomolecules · doi:10.3390/biom11111726 · Cited by 19
Potential role of membrane-bound COMT gene polymorphisms in female depression vulnerability
Hatzimanolis, A., Vitoratou, S., Mandelli, L., Vaiopoulos, C., Nearchou, F., Stefanis, C. N., Serretti, A., & Stefanis, N. C. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.018 · Cited by 20
Salatino‐Oliveira, A., Genro, J. P., Guimarães, A. P., Chazan, R., Zeni, C., Schmitz, M. D., Polanczyk, G. V., Roman, T., Rohde, L. A., & Hutz, M. H. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0766-2 · Cited by 18
Wright, G. E. B., Niehaus, D. J. H., van der Merwe, L., Koen, L., Korkie, L., Kinnear, C. J., Drögemöller, B. I., & Warnich, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.006 · Cited by 18
Pihlavisto, P., & Reenilä, I. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00429-4 · Cited by 18
Srivastava, K., Ochuba, O., Sandhu, J. K., Alkayyali, T., Ruo, S. W., Waqar, A., Jain, A. K., Joseph, C. G., & Poudel, S. (2021) · Cureus · doi:10.7759/cureus.18311 · Cited by 17
Lennard, L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00421-8 · Cited by 17
Metadata
- Authors
- TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I.
- Affiliations
- Orion Corporation (Finland) (FI)
- Helsinki University Hospital (FI)
- Corresponding author
- TENHUNEN, Jukka
- ORCID
- SALMINEN, Marjo
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 223
- Issue
- 3
- Pages
- 1049-1059
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2135835694
- Cited by
- 331
- References
- 38
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 13 · 2018: 2 · 2017: 6 · 2016: 15 · 2015: 4 · 2014: 14 · 2013: 16 · 2012: 12
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- catechol-O-methyltransferase, COMT gene, gene structure, exon-intron organization, alternative transcription initiation, multiple promoters, proximal promoter, distal promoter, tissue-specific gene expression, membrane-bound COMT, 5' end mapping
- MeSH terms
- Animals, Base Sequence, Catechol O-Methyltransferase, Exons, Humans, Introns, Molecular Sequence Data, Promoter Regions, Genetic, RNA, Messenger, Sequence Homology, Nucleic Acid, Tissue Distribution, Transcription, Genetic, Genomic Library, Sequence Analysis, DNA, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review